Editorial
doi: 10.1093/infdis/jis727.
Epub 2012 Nov 29.
The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic
- PMID: 23204176
- PMCID: PMC7313909
- DOI: 10.1093/infdis/jis727
Item in Clipboard
Editorial
The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic
J Infect Dis.
.
No abstract available
Comment on
-
Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.J Infect Dis. 2013 Feb 15;207(4):553-63. doi: 10.1093/infdis/jis726. Epub 2012 Nov 29. J Infect Dis. 2013. PMID: 23204175 Free PMC article. Review.
Similar articles
-
[Neuraminidase inhibitors - lessons from the swine flu].Praxis (Bern 1994). 2013 May 22;102(11):687-8. doi: 10.1024/1661-8157/a001301. Praxis (Bern 1994). 2013. PMID: 23692909 German. No abstract available.
-
Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.J Infect Dis. 2013 Feb 15;207(4):553-63. doi: 10.1093/infdis/jis726. Epub 2012 Nov 29. J Infect Dis. 2013. PMID: 23204175 Free PMC article. Review.
-
Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic.J Clin Virol. 2011 Feb;50(2):183. doi: 10.1016/j.jcv.2010.10.019. Epub 2010 Nov 26. J Clin Virol. 2011. PMID: 21112812 No abstract available.
-
Antivirals for pandemic influenza: a triumph of policy over evidence?Trends Pharmacol Sci. 2010 Sep;31(9):391-3. doi: 10.1016/j.tips.2010.05.005. Epub 2010 Jun 22. Trends Pharmacol Sci. 2010. PMID: 20573406 No abstract available.
-
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Expert Rev Anti Infect Ther. 2011. PMID: 21973296 Review.
Cited by
-
Seasonal and pandemic influenza: 100 years of progress, still much to learn.Mucosal Immunol. 2020 Jul;13(4):566-573. doi: 10.1038/s41385-020-0287-5. Epub 2020 Apr 21. Mucosal Immunol. 2020. PMID: 32317736 Free PMC article. Review.
-
Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Antimicrob Resist Infect Control. 2014 Jan 10;3(1):2. doi: 10.1186/2047-2994-3-2. Antimicrob Resist Infect Control. 2014. PMID: 24405855 Free PMC article.
-
Avian influenza A (H7N9) infections: intensivists as virus hunters in the new century.J Crit Care. 2013 Aug;28(4):528-30. doi: 10.1016/j.jcrc.2013.05.001. Epub 2013 May 21. J Crit Care. 2013. PMID: 23706866 Free PMC article. No abstract available.
References
-
- Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam J. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009–10 influenza A (H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis. 2013;207:553–63. - PMC - PubMed
-
- Adisasmito W, Chan PKS, Lee N, et al. strengthening observational evidence for antiviral effectiveness in influenza A (H5N1) J Infect Dis. 2011;204:810–11. - PubMed
-
- Chan PKS, Lee N, Zaman M, et al. Determinants of viral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012;206:1359–66. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
